SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0000950144-09-004176
Filing Date
2009-05-11
Accepted
2009-05-11 16:29:13
Documents
10
Period of Report
2009-03-31
Filing Date Changed
2009-05-11

Document Format Files

Seq Description Document Type Size
1 10-Q g18723e10vq.htm 10-Q 1124565
2 EX-10.1 g18723exv10w1.htm EX-10.1 41533
3 EX-10.2 g18723exv10w2.htm EX-10.2 36227
4 EX-10.3 g18723exv10w3.htm EX-10.3 29002
5 EX-10.4 g18723exv10w4.htm EX-10.4 33789
6 EX-10.5 g18723exv10w5.htm EX-10.5 38328
7 EX-31.1 g18723exv31w1.htm EX-31.1 8969
8 EX-31.2 g18723exv31w2.htm EX-31.2 8961
9 EX-32.1 g18723exv32w1.htm EX-32.1 3690
10 EX-32.2 g18723exv32w2.htm EX-32.2 3688
  Complete submission text file 0000950144-09-004176.txt   1330120
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15875 | Film No.: 09815404
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1